Brief: Biora Therapeutics Announces Successful Completion Of Device Performance Study In Ulcerative Colitis Patients For Its Targeted Therapeutics Platform

Biora Therapeutics

10/08/2022 14:20

Aug 10 (Reuters) - Biora Therapeutics Inc  BIOR.O :
    * BIORA THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF
DEVICE
PERFORMANCE STUDY IN ULCERATIVE COLITIS PATIENTS FOR ITS
TARGETED THERAPEUTICS PLATFORM
    * BIORA THERAPEUTICS INC - STUDY DEMONSTRATED THAT DEVICE
WAS WELL
TOLERATED
    * BIORA THERAPEUTICS INC -  STUDY DEMONSTRATED THAT DEVICE
PERFORMED AS INTENDED IN ACTIVE ULCERATIVE COLITIS (UC) PATIENTS
    * BIORA THERAPEUTICS INC - NO INVESTIGATIONAL DRUG WAS
ADMINISTERED DURING STUDY
    * BIORA THERAPEUTICS -  STUDY EVALUATING LOCALIZATION AND
DELIVERY
FUNCTION OF A DRUG DELIVERY SYSTEM CAPSULE IN SUBJECTS WITH
ULCERATIVE COLITIS

Source text for Eikon:  ID:nGNX8ccMJh 
Further company coverage:  BIOR.O 

 ((reuters.briefs@thomsonreuters.com;))